Patent · US Active

Pharmacokinetics of combined release formulations of a γ-hydroxybutyric acid derivative

US11510892B2 · kind B2 · utility

0Cited by

15References

15Claims

0Family size

Assignee

XWPHARMA LTD. · KY

Inventors

DANIEL M. CANAFAX · Rue de l'Église, US
WILLIAM W. XIANG · Fremont, US
LEONARD BLUM · Edina, US
Jia-Ning Xiang · Palo Alto, US

Key dates

Filing date	Mar 18, 2022
Grant date	Nov 29, 2022
Priority date	—
Expiry date	Mar 18, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions comprising an immediate release component comprising 4-((L-valyl)oxy)butanoic acid and a modified release component comprising 4-((L-valyl)oxy)butanoic acid and the pharmacokinetics of 4-((L-valyl)oxy)butanoic acid and γ-hydroxybutyrate following oral administration of the pharmaceutical compositions is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.